首页> 外文期刊>Journal of the American Academy of Dermatology >Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses
【24h】

Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses

机译:短时光动力学疗法与甲基氨基乙酰丙酸酯一起治疗无光化性角化病

获取原文
获取原文并翻译 | 示例
           

摘要

Methylaminolevulinate (MAL) is a porphyrin precursor approved for the treatment of actinic keratoses (AKs) of the face and scalp. The approved protocol combines topical application of MAL to individual lesions under occlusion for 3 hours followed by 37 J/cm2 of red light.1 This procedure is difficult to perform when AKs are numerous, ill defined, and widespread. The goal of the present study was to evaluate the effects of photodynamic therapy (PDT) performed with MAL without occlusion and with an incubation time of 90 minutes in patients with multiple AKs of the face.
机译:甲基氨基乙酰丙酸酯(MAL)是一种卟啉前体,被批准用于治疗面部和头皮的光化性角化病(AKs)。批准的方案将MAL局部应用在闭塞状态下3个小时,然后用37 J / cm2的红光进行局部涂药。1当AK数量众多,定义不清且分布广泛时,很难执行此程序。本研究的目的是评估在无面部阻塞的情况下使用MAL进行光动力学疗法(PDT)的效果,该疗法在具有多个面部AK的患者中的潜伏时间为90分钟。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号